This week HBI breaks down data from France's statutory insurer to see how it has changed since 2017. It makes clear just how much the ongoing COVID-19 pandemic has upset ongoing trends.
Not all of the PMI-funded treatments deferred by the COVID-19 crisis will be treated once it's over. One private insurer is modelling for just 50-60% of those claims to ever come back.
Pan-European nursing home group Orpea has acquired a training academy in Austria, HBI can reveal. It signals a new wave for the group, which tells HBI that it wants to be known in five to ten years as a school, alongside its care and property arms. It will use the licence to build a university campus, doubling the number of people trained locally, and then duplicate this model across all its markets.
UK-based fertility clinic specialist Bourn Hall has secured "significant investment" from Triangle Capital Corporation, a Canadian-based investment firm, in partnership with Toronto-based Bulldog Capital Partners.
India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.
The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.
Just 2% of publicly insured Germans have registered to see their electronic patient record (ePA) since access was made mandatory at the beginning of the year. Many either don't know it exists or are worried about data privacy, HBI hears. That settles some answers to the question of whether it's worthwhile giving patients access to their own data.
France's largest lab group Biogroup is reportedly continuing its consolidation of the French market and in exclusive negotiations to acquire much smaller competitor Oriade Noviale.
Analysts covering Brazil's largest private hospital Rede d'Or have projected a 25% rise share price after its $2.2bn IPO last month. However, the sustainability of its fee-for-service business model in the long-term has been questioned by some. Its insurers are slowly losing market cap to integrated players.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
